Brief: HLS Therapeutics Reports Q3 Loss Per Share Of $0.72

HLS Therapeutics

15/11/2018 11:41

Nov 15 (Reuters) - HLS Therapeutics Inc  HLS.V :
    * HLS THERAPEUTICS ANNOUNCES Q3 2018 FINANCIAL RESULTS
    * QTRLY LOSS PER SHARE $0.72
    * Q3 LOSS PER SHARE $0.72
    * ESTABLISHMENT OF A DIVIDEND POLICY PROVIDING FOR PAYMENT
OF
QUARTERLY DIVIDENDS OF C$0.05 PER COMMON SHARE
    * QTRLY REVENUE $15.3 MILLION VERSUS $20.3 MILLION
    * AS OF SEPT 30, CO HAD CASH AND CASH EQUIVALENTS OF $9.9
MILLION
VERSUS $36.2 MILLION AT DEC 31, 2017

Source text for Eikon:  ID:nCNW7JlF6a 
Further company coverage:  HLS.V 

 (Reuters.Briefs@thomsonreuters.com)